Study number 776671
Dates
Mar 05 2026-May 08 2026
Location
Madison, Wisconsin
Age
18-60
Gender
Male and Female
Smoker
Yes
Compensation
$9,429
Group
C5 or C9
This study drug is a medication approved for the treatment of hypercholesterolemia (increased blood cholesterol level) and prevention of cardiovascular events (for example, heart attack and stroke) in adults with cardiovascular disease. The use of the study drug in this study is investigational.
Madison, WI is currently recruiting Healthy Adults, ages 18-60.
Refer a friend & receive $350 per qualified referral
Women Eligibility Criteria
Body Mass Index
Screening procedures
C5
Check-in: Mar 5
Check-out: Mar 13
Follow-up visit: Mar 16, 20, 27, Apr 3, 10, 17, 24, May 1, 8
OR
C9
Check-in: Mar 25
Check-out: Apr 2
Follow-up visit: Apr 5, 9, 16, 23, 30, May 7, 14, 21, 28